Does the FDA prefer patches over pills

DISCLOSURE: Voshell's Pharmacy is a licensed compounding pharmacy that prepares and sells compounded medications by prescription. As a provider of competing products, our perspective may be influenced by our professional and commercial interests.

According to FDA.gov, the FDA does not prefer patches over pills. The FDA's role is to review both forms for safety and effectiveness; it does not rank them. Many clinicians discuss patches more often because research shows certain delivery-method differences that may matter for some women.

What the FDA actually does

According to FDA.gov, the FDA reviews every estrogen pill and every estrogen patch to verify that each one is safe, effective, and manufactured correctly. It does not recommend one form over another. The choice is left to women and their qualified prescribers. Compounded medications are not reviewed by FDA for safety or effectiveness before dispensing and are prepared by a licensed pharmacist only in response to a valid prescription for an individual patient. This page primarily discusses commercially available hormone therapy products.

Why many clinicians lean toward patches

Even though the FDA does not state a preference, patches have some practical and delivery-related differences supported by large studies, including the WHI. According to the WHI, these findings influence real-world prescribing:

• Lower clot risk: Pills pass through the liver first, increasing proteins that may promote blood clots. According to NAMS, patches deliver estrogen through the skin, avoiding that liver surge, so studies consistently show lower observed rates of deep vein thrombosis and pulmonary embolism.
• Gentler on triglycerides: Oral estrogen may raise triglycerides (a type of blood fat). Patches generally have neutral or minimal effect, which may matter for women with metabolic issues.
• More stable hormone levels: Patches release estrogen evenly, which may mean smoother symptom control for some women.
• Lower nausea risk: Because patches bypass the stomach and liver, they may cause less nausea or bloating in some individuals.

When pills might still be a good choice

• Lower cost or easier access: Some women prefer pills because they are familiar and often less expensive.
• No skin sensitivity: If a woman reacts to adhesives, pills may be more comfortable.
• Preference for ease: Swallowing a pill feels simpler for some individuals.

The bottom line

According to FDA.gov, the FDA approves both pills and patches without stating a preference. In practice, many clinicians discuss patches with women who wish to address clotting risk factors and seek steadier hormone levels. Both forms are commercially available, subject to FDA review, and require a prescription. Discuss your health profile, comfort, and goals with a qualified prescriber to determine which form may be appropriate for you.